Blood and Blood Components Market Analysis and Forecast by 2031

MARKET INTRODUCTION

Blood, a living tissue circulating throughout the human body, is comprised of red blood cells, white blood cells, platelets and plasma. Although often collected as whole blood and separated into major components prior to transfusion, automated collections. In the U.S., the collection, testing, preparation, storage and transport of blood and blood components is governed by FDA regulations and guidance documents.

MARKET DYNAMICS

Increase in geriatric population, For instance, As per Population Reference Bureau, U.S. population aged 65 years is estimated to double till 2060. Moreover, rise in incidence in trauma cases, rising prevalence of target diseases will propel the market growth. Furthermore, advancement in blood transfusion instruments, such as, Haemonetics Corporation (US) in 2021, the company received the US FDA approval for NexSys PCS embedded software and NexSys PCS plasmapheresis system which is used for blood plasma separation will offer lucrative opportunities. However, minimal invasive technology, which no longer need the blood transfusion, hampers the market growth.

MARKET SCOPE

The "Global Blood and Blood Components market analysis to 2031" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of Blood and Blood Components market with detailed market segmentation by type, product, application, end-users and geography. The global Blood and Blood Components market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Blood and Blood Components market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global Blood and Blood Components market is segmented on the basis of type, product, application, and end-users. Based on type, the market is segmented as whole blood and blood components. Blood Components segment is further bifurcated into plasma, red blood cells, white blood cells, platelets. In terms of product, the market can be divided into systems and reagents. Based on, applications the market is divided into anemia, trauma & surgery, cancer treatment, and bleeding disorders among others. Based on, end-user the market is divided into blood & blood component bank, diagnostic laboratories, ambulatory surgical centers, hospitals, others

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Global Blood and Blood Components market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Blood and Blood Components market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Blood and Blood Components market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Blood and Blood Components market in these regions.

MARKET PLAYERS

The report covers key developments in the Blood and Blood Components market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Blood and Blood Components market are anticipated to lucrative growth opportunities in the future with the rising demand for Blood and Blood Components market in the global market. Below mentioned is the list of few companies engaged in the Blood and Blood Components market.

The report also includes the profiles of key Blood and Blood Components market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

•  Abbott Laboratories
•  Baxter International Inc.
•  Becton, Dickinson & Co.
•  CSL Behring
•  Immucor
•  Novartis
•  Novo Nordisk
•  Ortho Clinical Diagnostics
•  Roche Diagnostics
•  Grifols International SA.

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Blood and Blood Components Report Scope